Journals / Bakırköy Tıp Dergisi / 2013 / Cilt: 9 - Sayı: 1

Cirrhotic ascites

Sirotik asit

Pages
1–7
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, clinic, pathophysiologic and diagnostic features and treatment of cirrhotic ascites are reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ascites is the accumulation of free fluid within the peritoneal cavity.
📊
Key Findings & Data:Approximately 85% of cases of ascites are due to liver cirrhosis.
💡
Conclusion & Impact:In this article, clinic, pathophysiologic and diagnostic features and treatment of cirrhotic ascites are reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Ascites is the accumulation of free fluid within the peritoneal cavity. In a patient with new-onset ascites, diagnostic paracentesis should be always performed regardless of the cause. Approximately 85% of cases of ascites are due to liver cirrhosis. In about 15% of patients with ascites, there is nonhepatic cause of fluid retention. Ascites is the most common major complication of cirrhosis. Approximately 50% of patients with compensated cirrhosis develop ascites during 10 years of observation, and cirrhotic patients with ascites are associated with a 50% mortality over two years. In this article, clinic, pathophysiologic and diagnostic features and treatment of cirrhotic ascites are reviewed.

Özet

Asit, periton boşluğunda serbest sıvı toplanması şeklinde tanımlanmaktadır. Nedeni ne olursa olsun, asit ilk saptandığında her olguda parasentez yapılarak tetkik edilmelidir. Asit nedeni, %85 olguda karaciğer sirozu iken, diğer olgularda nonhepatik nedenler saptanmaktadır. Asit, karaciğer sirozunun en sık görülen major komplikasyonu olup, kompanse sirozlu hastaların ortalama yarısında 10 yıllık bir takip süresi içinde ortaya çıkmakta; asit geliştikten sonra iki yıllık sağ kalım oranı ise ortalama %50 civarında bulunmaktadır. Bu yazıda sirotik asitin klinik, patofizyolojik ve tanısal özellikleri ile tedavisi incelenmiştir.

🔖

Cite This Article

ÖZDEMİR, S. (2013). Cirrhotic ascites. Bakırköy Tıp Dergisi, Cilt: 9 - Sayı: 1, 1–7. https://ajindex.com/articles/129135

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Sherlock S, Dooley J (Eds). Diseases of the Liver and Biliary System. 11th ed. Oxford; Blackwell Science; 2002: p. 365-380
  2. Reynolds TB. Ascites. Clin Liver Dis 2000; 4: 151-168
  3. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-128
  4. Lucena MI, Andrade RJ, Tognoni G, et al. Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis. Eur J Clin Pharmacol 2002; 58: 435-440
  5. D’Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-475
  6. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003; 38: S69-S89
  7. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-266
  8. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-856
  9. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009; 49: 2087-2107
  10. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23: 164-176
  11. Cardenas A, Gines P. Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis. Semin Nephrol 2001; 21: 308-316
  12. Rosner MH, Gupta R, Ellison D, Okusa MD. Management of cirrhotic ascites: physiological basis of diuretic action. Eur J Intern Med 2006; 17: 8-19
  13. Sonsuz A. Asit. In: Altıparmak MR, Hamuryudan V, Sonsuz A, Yazıcı H (Eds). Cerrahpaşa İç Hastalıkları. 2. baskı, İstanbul Medikal Yayıncılık; İstanbul; 2012: s. 1133-1138
  14. Korthuis RJ, Kinden DA, Brimer GE, Slattery KA, Stogsdill P, Granger DN. Intestinal capillary filtration in acute and chronic portal hypertension. Am J Physiol 1988; 254: G339-G345
  15. Rector WG Jr. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver 1986; 6: 221- 226
  16. Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol 2003; 38 Suppl 1: S54-S68
  17. Moller S, Henriksen JH, Bendtsen F. Pathogenetic background for treatment of ascites and hepatorenal syndrome. Hepatol Int 2008; 2: 416-428
  18. Casado M, Bosc